PREGANERVE

This brand name is authorized in Nigeria.

Active ingredients

The drug PREGANERVE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 55JG375S6M - PREGABALIN
 

Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system.
 
Read more about Pregabalin
2
UNII BR1SN1JS2W - METHYLCOBALAMIN
 

Methylcobalamin is a cobalamin, a form of vitamin B12. Mecobalamin is a kind of endogenous coenzyme B12. Mecobalamin plays an important role in transmethylation as a coenzyme of methionine synthetase in the synthesis of methionine from homocysteine. Mecobalamin promotes axonal transport and axonal regeneration. Mecobalamin promotes myelination (phospholipid synthesis). Methylcobalamin is used in the treatment of peripheral neuropathy, diabetic neuropathy, and as a preliminary treatment for amyotrophic lateral sclerosis.
 
Read more about Mecobalamin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
C4-1420 Capsule Preganerve Capsules CAP 75 mg; 750 mcg 21/12/2020

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database C4-1420

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈